Exelixis | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 20.1M 2M 2025-06
Agios Pharmaceuticals USD 17.53M 3.81M 2025-06
Amgen USD 18.03B 15.63B 2025-06
AstraZeneca 23.99B 1.44B 2025-06
Bayer EUR 6.59B 931M 2025-03
BioMarin Pharmaceutical 684.25M 390.5M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Cytokinetics USD 68.54M 54.6M 2025-06
Eisai JPY 82.98B 8.59B 2025-06
Eli Lilly USD 4.08B 633.7M 2025-06
Exelixis USD 25.82M 17.02M 2025-07
Genmab 5M 1.22M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 1.41B 1.21B 2025-06
Ionis Pharmaceuticals USD 22.8M 5.34M 2025-06
MacroGenics USD 5.01M 1.6M 2024-12
Merck USD 4.04B 261M 2025-06
Moderna USD 175M 51M 2025-06
Neurocrine Biosciences 104.6M 5.4M 2025-06
Novartis USD 4.51B 245M 2025-06
Pfizer USD 5.17B 74M 2025-06
Sanofi 7.55B 118M 2024-12
Takeda JPY 421.31B 54.23B 2025-06
Ultragenyx Pharmaceutical USD 34.24M 13.21M 2025-06
Xencor USD 16.19M 568K 2025-03


Exelixis Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.